Procurement Summary
Country: Argentina
Summary: Urgent Acquisition of Medicines - Annex Ii (Deserted and Failed)
Deadline: 06 Apr 2026
Posting Date: 03 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 138929355
Document Ref. No.: 401-0237-CDI26
Competition: NCB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: ARS 611315436.50
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
POSACONAZOLE. Model: In oral suspension 40 mg/ml, DINOPROSTONE. Model: 10 mg, vaginal release system, CASPOFUNGIN 50 mg. Model: Caspofungin Acetate 60.6 mg (equivalent to 54.6 anhydrous free acid), injectable, lyophilized, in a bottle ampoule, intravenous use, CASPOFUNGIN 70 mg. Model: Caspofungin Acetate 83.9 mg (equivalent to 75.6 mg of anhydrous free acid), injectable, lyophilized, in a vial, intravenous use, FLOROGLUCINOL + TRIMETHOXYBENZENE. Model: 40 mg Phloroglucinol + 40 mg of 1, 3, 5 Trimethoxybenzene, injectable, in vial, SPIRAMYCIN. Model: 1000 mg, tablet
File number: EX-2026-12703950- -GCABA-DGACSA Legal framework: Law N? 2, 095 (Consolidated Text by Law No. 6, 588) and Decree No. 129/23 Art. 29 Other conditions: Requires technical advice Responsible area: Technical Support Operational Deputy Manager More info: Place of receipt of physical documentation: Rivadavia 524, 4th floor, DGACSA Office
Documents
Tender Notice